Seed-stage investor centered on data-centric, moat-driven emerging ventures; founder-first (no board seats, won't vote founders out), features mature-phase operating support at seed and limits partners to 6–8 companies. The firm continues to build its presence across the venture capital landscape.
Ranked by shared stages, industries, geography, cheque size and investor type. 400 related investors in the directory.
Acts as a VC and venture studio—co-founds emerging ventures with 25–30% of capital, assembles top‑1% specialists, and builds national‑capability defense, industrials, and bio‑infrastructure companies with corporate partners. The firm continues to build its presence across the venture capital landscape.
Invests very early (seed, $1–3M) with a solo GP enabling rapid decisions, leveraging an operator-heavy LP network for sourcing and delivering data-driven diagnostics plus structured playbooks to find PMF. The firm continues to build its presence across the venture capital landscape.
Leads seed, doubles down at Series A, and incubates emerging ventures; an unusually operator-heavy founding team (Eventbrite founder, ex-Uber finance head, ex-Coatue investor) features hands-on operational, finance, and growth support. With a disciplined investment approach, the team drives value for both founders and investors.
Centered on relocating early-phase companies—especially from Latin America—to Tulsa via investments and coordinated city-building programs, with growth measured by financial returns and local employment outcomes. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
Pre-seed investor writing the first institutional check, operating a Venice entrepreneurial campus where founders and investors co-work, with Hollywood-connected mentors providing direct access to celebrity, media and brand networks. The firm continues to build its presence across the venture capital landscape.
Venture studio and fund that co‑incubates with LifePoint executives, giving startup ventures direct access to a $50B+ health system for pilot deployment, real‑world validation, and underserved population focus. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
